A new English study confirms the risks of ulcers and other gastrointestinal issues with the use of acetaminophen in people over 65 and calls for its reassessment as a first-line treatment.
The number of molecules linked to cardiovascular disease shows significant changes at these two ages, while those linked to immune function change in the early 60s.